MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, XFOR has $270,281K in assets. $101,831K in debts. $216,908K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1017.97%
Quick Ratio
1017.97%
Cash Ratio
912.49%
Debt to Asset Ratio
37.68%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Goodwill
    • Marketable securities
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Long-term debt, including accret...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
216,908 217,049 69,632 39,220
Accounts receivable
1,113 573 891 1,145
Marketable securities
16,812 35,949 52,562 23,731
Research and development incentive receivable
-0 715 720
Inventory
4,637 4,479 4,080 3,170
Prepaid expenses and other current assets
2,512 3,527 4,925 4,956
Total current assets
241,982 261,577 132,805 72,942
Property and equipment, net
146 182 218 254
Goodwill
17,351 17,351 17,351 17,351
Intangible asset, net
9,063 9,250 9,438 9,625
Right-of-use assets
1,035 1,409 1,775 2,646
Other assets
704 692 1,968 2,350
Total assets
270,281 290,461 163,555 105,168
Accounts payable
5,073 5,696 5,053 7,709
Accrued expenses
17,055 18,603 16,661 13,065
Deferred revenue
910 464 592 754
Current portion of lease liability
733 994 1,200 1,368
Total current liabilities
23,771 25,757 23,506 22,896
Long-term debt, including accretion, net of discount
76,520 76,291 76,062 75,841
Lease liabilities
-0 95 815
Warrant liability
897 977 959 283
Deferred revenue
117 621 789 827
Other liabilities
526 525 525 535
Total liabilities
101,831 104,171 101,936 101,197
Common stock, 0.001 par value, 500,000,000 shares authorized as of march31, 2026 and december31, 2025, respectively 94,319,696 and 90,906,920 shares issued and outstanding as of march31, 2026 and december31, 2025, respectively
94 91 25 8
Additional paid-in capital
783,273 780,862 632,341 544,915
Accumulated other comprehensive loss
-122 -109 -118 -138
Accumulated deficit
-614,795 -594,554 -570,629 -540,814
Total stockholders equity
168,450 186,290 61,619 3,971
Total liabilities and stockholders equity
270,281 290,461 163,555 105,168
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$216,908K Marketable securities$16,812K Inventory$4,637K Prepaid expenses andother current assets$2,512K Accounts receivable$1,113K Total current assets$241,982K Goodwill$17,351K Intangible asset, net$9,063K Right-of-use assets$1,035K Other assets$704K Property and equipment,net$146K Total assets$270,281K Total liabilities andstockholders equity$270,281K Total stockholdersequity$168,450K Total liabilities$101,831K Accumulated deficit-$614,795K Accumulated othercomprehensive loss-$122K Additional paid-in capital$783,273K Long-term debt, includingaccretion, net of discount$76,520K Total currentliabilities$23,771K Warrant liability$897K Other liabilities$526K Deferred revenue$117K Common stock, 0.001 parvalue, 500,000,000...$94K Accrued expenses$17,055K Accounts payable$5,073K Deferred revenue$910K Current portion of leaseliability$733K

X4 Pharmaceuticals, Inc (XFOR)

X4 Pharmaceuticals, Inc (XFOR)